Estudio comparativo para establecer la eficacia y seguridad de omeprazol 40 mg vs. esomeprazol 40 mg en pacientes con enfermedad por reflujo gastroesofágico no erosivo (ERNE)

Comparative study to determine the efficacy and safety of 40 mg omeprazol vs. 40 mg esomeprazol in patients with non-erosive gastro-esophageal reflux disease (NERD)

Juan Miguel Abdo-Francisa, José Luis Pérez-Hernándeza, Ceriolith Tenorio-Floresa, Edwin Ornelas-Escobedoa, Eduardo Pérez-Torresa, Fernando Bernal-Sahagúna

a Servicio de Gastroenterología. Hospital General de México. México, D. F.

Read

90962

Times
was read the article

10208

Total PDF

80754

Total HTML

Share statistics

Article information

ISSN: 01851063
Original language: Spanish

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 12	577	27	604
2025 11	1003	89	1092
2025 10	1021	71	1092
2025 9	1065	79	1144
2025 8	1177	85	1262
2025 7	1013	47	1060
2025 6	1163	56	1219
2025 5	1311	97	1408
2025 4	1379	101	1480
2025 3	1693	76	1769
2025 2	1660	80	1740
2025 1	1804	65	1869
2024 12	2120	79	2199
2024 11	2296	87	2383
2024 10	2047	122	2169
2024 9	2527	121	2648
2024 8	2676	91	2767
2024 7	1846	66	1912
2024 6	1090	52	1142
2024 5	993	45	1038
2024 4	880	34	914
2024 3	979	37	1016
2024 2	1090	32	1122
2024 1	1261	39	1300
2023 12	1418	76	1494
2023 11	1190	52	1242
2023 10	1170	63	1233
2023 9	971	28	999
2023 8	1030	33	1063
2023 7	1053	66	1119
2023 6	1002	56	1058
2023 5	947	77	1024
2023 4	495	57	552
2023 3	421	29	450
2023 2	333	28	361
2023 1	241	37	278
2022 12	214	41	255
2022 11	432	37	469
2022 10	347	50	397
2022 9	269	40	309
2022 8	389	57	446
2022 7	389	28	417
2022 6	320	30	350
2022 5	374	40	414
2022 4	343	36	379
2022 3	466	48	514
2022 2	400	35	435
2022 1	356	54	410
2021 12	321	43	364
2021 11	423	60	483
2021 10	581	92	673
2021 9	423	44	467
2021 8	520	38	558
2021 7	666	26	692
2021 6	791	40	831
2021 5	806	31	837
2021 4	1532	76	1608
2021 3	730	52	782
2021 2	425	51	476
2021 1	410	36	446
2020 12	461	64	525
2020 11	392	36	428
2020 10	383	41	424
2020 9	494	36	530
2020 8	458	33	491
2020 7	441	18	459
2020 6	407	27	434
2020 5	510	52	562
2020 4	703	89	792
2020 3	626	43	669
2020 2	522	59	581
2020 1	355	49	404
2019 12	226	58	284
2019 11	299	81	380
2019 10	273	73	346
2019 9	267	111	378
2019 8	214	162	376
2019 7	158	202	360
2019 6	172	205	377
2019 5	231	292	523
2019 4	173	452	625
2019 3	104	404	508
2019 2	94	545	639
2019 1	84	454	538
2018 12	70	142	212
2018 11	137	21	158
2018 10	63	32	95
2018 9	45	139	184
2018 8	75	321	396
2018 7	30	221	251
2018 6	36	213	249
2018 5	49	235	284
2018 4	45	187	232
2018 3	50	118	168
2018 2	26	55	81
2018 1	40	69	109
2017 12	41	53	94
2017 11	63	74	137
2017 10	64	42	106
2017 9	88	47	135
2017 8	73	63	136
2017 7	59	42	101
2017 6	93	63	156
2017 5	52	45	97
2017 4	47	60	107
2017 3	36	49	85
2017 2	79	30	109
2017 1	44	18	62
2016 12	28	11	39
2016 11	31	16	47
2016 10	59	18	77
2016 9	33	4	37
2016 8	22	1	23
2016 7	212	24	236
2016 6	467	51	518
2016 5	407	43	450
2016 4	334	56	390
2016 3	220	30	250
2016 2	163	42	205
2016 1	132	39	171
2015 12	136	42	178
2015 11	163	38	201
2015 10	226	70	296
2015 9	165	36	201
2015 8	141	30	171
2015 7	158	20	178
2015 6	128	20	148
2015 5	117	18	135
2015 4	99	26	125
2015 3	112	18	130
2015 2	91	17	108
2015 1	188	13	201
2014 12	321	13	334
2014 11	350	11	361
2014 10	354	8	362
2014 9	322	14	336
2014 8	334	11	345
2014 7	417	10	427
2014 6	373	12	385
2014 5	256	8	264
2014 4	273	12	285
2014 3	286	7	293
2014 2	269	9	278
2014 1	355	9	364
2013 12	405	13	418
2013 11	283	15	298
2013 10	376	15	391
2013 9	412	22	434
2013 8	464	32	496
2013 7	345	14	359
2011 9	4406	0	4406

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter